DNV GL Healthcare COVID-19 Resources

Contact us:

Have questions?

Contact Us

This page combines all of our communications and resources with regards to COVID-19. If you have any suggestions for this page or unanswered questions, please email dnvclientdropbox@dnvgl.com.

Contact us:

Have questions?

Contact Us

Resource Links

CMS Coronavirus Waivers & Flexibilities

CMS 1135 Waiver Fact Sheet

March 13, 2020

CMS QSO-20-20

Subject: Prioritization of Survey Activities

CDC Preparedness Checklist

FDA Ventilator Supply Mitigation

Respirator Guidance

FDA Response and Information Regarding COVID-19

FDA Reissues Emergency Use Authorizations Revising Which Types of Respirators Can Be Decontaminated for Reuse

June 07, 2020

Secretary Azar COVID-19 Governors Letter

March 24, 2020

CMS QSO-20-21-CLIA Combined

Subject: Clinical Laboratory Improvement Amendments (CLIA) Laboratory Guidance During COVID-19 Public Health Emergency

CDC Guidance for Universal Source Control

CMS Guidance for Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase 1

ACS Guidance on Resuming Elective Procedures

OSHA Response and Information Regarding COVID-19

CDC Summary Strategies to Optimize the Supply of PPE during Shortages

DNV GL Healthcare Client Dropbox

Send any questions you have to: dnvclientdropbox@dnvgl.com

Stay up to date with all of our communications

Subscribe to our Email List

Receive emails regarding advisory notices, upcoming events/webinars and our newsletter.

Follow DNV GL on LinkedIn

Follow DNV GL Healthcare on Twitter

Connect with our President, Patrick Horine, on LinkedIn

Healthcare Advisory Notices

Healthcare Customer Communications